Coordinated Regulation of Vascular Ca2+ and K+ Channels by Integrin Signaling

  • Peichun Gui
  • Jun-Tzu Chao
  • Xin Wu
  • Yan Yang
  • George E. Davis
  • Michael J. Davis
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 674)


A role for integrins in mechanotransduction has been suggested because these molecules form an important mechanical link between the extracellular matrix (ECM) and the cytoskeleton. An example of mechanotransduction in blood vessels is the myogenic response—the rapid and maintained constriction of arterioles in response to pressure elevation. L-type calcium channels and large-conductance, calcium-activated potassium (BK) channels are known to play important roles in the myogenic response and in the maintenance of myogenic (pressure-induced) vascular tone. Our recent studies on isolated, cannulated arterioles and freshly-dispersed arteriolar smooth muscle cells show that both L-type calcium channels (Cav1.2) and BK channels are regulated by α5β1 integrin activation. α5β1 integrin interacts with the ECM protein fibronectin, which is distributed in basement membrane and interstitial matrices surrounding smooth muscle cells within the arteriolar wall. Truncation and site-directed mutagenesis strategies reveal that regulation of Cav1.2 by α5β1 integrin requires phosphorylation of the channel α1C subunit at C-terminal residues Ser-1901 and Tyr-2122. Likewise, BK channel potentiation by α5β1 integrin activation requires c-Src phosphorylation of the channel α-subunit at residue Tyr-766. Thus, both L-type calcium channels and BK channels can be regulated coordinately through integrin-linked phosphorylation cascades involving c-Src. We propose that these two channels are under constitutive control by α5β1 integrin-fibronectin interactions in the vessel wall such that the balance of their activity determines myogenic tone and the vascular response to vessel wall injury/remodeling.


Integrin Signaling Integrin Activation Myogenic Response Myogenic Tone Focal Adhesion Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vuori K. Integrin signaling: tyrosine phosphorylation events in focal adhesions. J Membr Biol 1998; 165(3):191–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Larsen M, Artym VV, Green JA et al. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 2006; 18(5):463–71.CrossRefPubMedGoogle Scholar
  3. 3.
    Schwartz MA. Integrin signaling revisited. Trends Cell Biol 2001; 11:466–470.CrossRefPubMedGoogle Scholar
  4. 4.
    Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285:1028–1032.CrossRefPubMedGoogle Scholar
  5. 5.
    Ingber DE. Cellular mechanotransduction: putting all the pieces together. FASEB J 2006; 20(7):811–27.CrossRefPubMedGoogle Scholar
  6. 6.
    Gao M, Sotomayor M, Villa E et al. Molecular mechanisms of cellular mechanics. Phys Chem Chem Phys 2006; 8(32):3692–706.CrossRefPubMedGoogle Scholar
  7. 7.
    Glukhova MA, Koteliansky VE. Integrins, cytoskeletal and extracellular matrix proteins in developing smooth muscle cells of human aorta. In: Schwartz SM and Mecham RP, eds. The Vascular Smooth Muscle Cell: Molecular and Biological Responses to the Extracellular Matrix. San Diego, CA: Academic 1995; 37–79.Google Scholar
  8. 8.
    Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 2005; 38(10):1949–71.CrossRefPubMedGoogle Scholar
  9. 9.
    Muller JM, Chilian WM, Davis MJ. Integrin signaling transduces shear stress-dependent vasodilation of coronary arterioles. Circ Res 1997; 80:320–326.PubMedGoogle Scholar
  10. 10.
    Madden JA, Christman NJ. Integrin signaling, free radicals and tyrosine kinase mediate flow constriction in isolated cerebral arteries. Am J Physiol (Heart Circ Physiol) 1999; 277:H2264–H2271.Google Scholar
  11. 11.
    Mogford JE, Davis GE, Platts SH et al. Vascular smooth muscle αvβ3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res 1996; 79:821–826.PubMedGoogle Scholar
  12. 12.
    Mogford JE, Davis GE, Meininger GA. RGDN peptide interaction with endothelial α5β1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles. J Clin Invest 1997; 100:1647–1653.CrossRefPubMedGoogle Scholar
  13. 13.
    Lipke DW, Soltis EE, Fiscus RR et al. RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings. Regul Pept 1996; 63:23–29.CrossRefPubMedGoogle Scholar
  14. 14.
    Yip KP, Marsh DJ. An Arg-Gly-Asp peptide stimulates constriction in rat afferent arteriole. Am J Physiol (Renal Physiol) 1997; 273:F768–F776.Google Scholar
  15. 15.
    Laplante C, St-Pierre S, Beaulieu AD et al. Small fibronectin fragments induce endothelium-dependent vascular relaxations. Can J Physiol Pharmacol 1988; 66:745–748.PubMedGoogle Scholar
  16. 16.
    Martinez-Lemus LA, Crow T, Davis MJ et al. αvβ3-and α5β1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. Am J Physiol (Heart Circ Physiol) 2005; 289:H322–9.CrossRefGoogle Scholar
  17. 17.
    Waitkus-Edwards KR, Martinez-Lemus LA, Wu X et al. α4β1Integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction. Circ Res 2002; 90(4):473–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Platts, SH, Mogford JE, Davis MJ et al. Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide. Am J Physiol (Heart Circ Physiol) 1998; 275:H1449–H1454.Google Scholar
  19. 19.
    Ledoux J, Werner ME, Brayden JE et al. Calcium-activated potassium channels and the regulation of vascular tone. Physiology 2006; 21:69–78.CrossRefPubMedGoogle Scholar
  20. 20.
    Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79(2):387–423.PubMedGoogle Scholar
  21. 21.
    D’Angelo, G, Mogford JE, Davis GE et al. Integrin-mediated reduction in vascular smooth muscle [Ca2+]i induced by RGD-containing peptide. Am J Physiol (Heart Circ Physiol) 1999; 272:H2065–H2070.Google Scholar
  22. 22.
    Wu, X, Mogford JE, Platts SH et al. Modulation of calcium current in arteriolar smooth muscle by αvβ3 and α5β1 integrin ligands. J Cell Biol 1998; 143:241–252.CrossRefPubMedGoogle Scholar
  23. 23.
    Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995; 267:883–885.CrossRefPubMedGoogle Scholar
  24. 24.
    Wu X, Davis GE, Meininger GA et al. Regulation of the L-type calcium channel by α5β1 integrin requires signaling between focal adhesion proteins. J Biol Chem 2001; 276:30285–30292.CrossRefPubMedGoogle Scholar
  25. 25.
    Wijetunge S, Hughes AD. pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Comm 1995; 217:1039–1044.CrossRefPubMedGoogle Scholar
  26. 26.
    Wijetunge S, Hughes AD. Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells. FEBS Lett 1996; 399:63–66.CrossRefPubMedGoogle Scholar
  27. 27.
    Hu XQ, Singh N, Mukhopadhyay D et al. Modulation of voltage-dependent Ca2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 1998; 273:5337–5342.CrossRefPubMedGoogle Scholar
  28. 28.
    Wijetunge S, Hughes AD. Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells. Br J Pharmacol 1995; 115:534–538.PubMedGoogle Scholar
  29. 29.
    Gui P, Balasubramanian BB, Wu X et al. Effect of α5β1 integrin activation on heterogenously expressed cardiac L-type calcium channel. Biophysical J 2004; 86(1) 427A.Google Scholar
  30. 30.
    Wang YG, Samarel AM, Lipsius SL. Laminin acts via β1 integrin signalling to alter cholinergic regulation of L-type Ca(2+) current in cat atrial myocytes. J Physiol 2000; 526(1):57–68.CrossRefPubMedGoogle Scholar
  31. 31.
    Wang YG, Samarel AM, Lipsius SL. Laminin binding to β1-integrins selectively alters beta1-and beta2-adrenoceptor signalling in cat atrial myocytes. J Physiol 2000; 527(1):3–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Gui P, Wu X, Ling S et al. Integrin receptor activation triggers converging regulation of Cav1.2 calcium channels by c-Src and protein kinase A pathways. J Biol Chem 2006; 281(20):14015–25.CrossRefPubMedGoogle Scholar
  33. 33.
    Chao J-T, Gui P, Zamponi G et al. Spatial association between L-type calcium channels and integrins. FASEB J 2007; 21(5):A914.Google Scholar
  34. 34.
    Lin CY, Hilgenberg LG, Smith MA et al. Integrin regulation of cytoplasmic calcium in excitatory neurons depends upon glutamate receptors and release from intracellular stores. Mol Cell Neurosci 2008; 37(4):770–80.CrossRefPubMedGoogle Scholar
  35. 35.
    Gall CM, Pinkstaff JK, Lauterborn JC et al. Integrins regulate neuronal neurotrophin gene expression through effects on voltage-sensitive calcium channels. Neuroscience 2003; 118(4):925–40.CrossRefPubMedGoogle Scholar
  36. 36.
    Stäubli U, Chun D, Lynch G. Time-dependent reversal of long-term potentiation by an integrin antagonist. J Neurosci 1998; 18(9):3460–9.PubMedGoogle Scholar
  37. 37.
    Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001; 89(12):1104–10.CrossRefPubMedGoogle Scholar
  38. 38.
    Bryan RM Jr, Marrelli SP, Steenberg ML et al. Effects of luminal shear stress on cerebral arteries and arterioles. Am J Physiol (Heart Circ Physiol) 2001; 280(5):H2011–22.Google Scholar
  39. 39.
    Leavesley DI, Schwartz MA, Rosenfeld M et al. Integrin β1-and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993; 121(1):163–70.CrossRefPubMedGoogle Scholar
  40. 40.
    Bhattacharya S, Ying X, Fu C et al. αvβ3 integrin induces tyrosine phosphorylation-dependent Ca2+ influx in pulmonary endothelial cells. Circ Res 2000; 86(4):456–62.PubMedGoogle Scholar
  41. 41.
    Kawasaki J, Davis GE, Davis MJ. Regulation of Ca2+-dependent K+ current by αvβ3 integrin engagement in vascular endothelium. J Biol Chem 2004; 279(13):12959–66.CrossRefPubMedGoogle Scholar
  42. 42.
    Daut J, Mehrke G, Nees S et al. Passive electrical properties and electrogenic sodium transport of cultured guinea-pig coronary endothelial cells. J Physiol 1988; 402:237–54.PubMedGoogle Scholar
  43. 43.
    Peppelenbosch MP, Tertoolen LG, de Laat SW. Epidermal growth factor-activated calcium and potassium channels. J Biol Chem 1991; 266(30):19938–44.PubMedGoogle Scholar
  44. 44.
    Sharma NR, Davis MJ. Mechanism of substance P-induced hyperpolarization of porcine coronary artery endothelial cells. Am J Physiol (Heart Circ Physiol) 1994; 266:H156–64.Google Scholar
  45. 45.
    Vaca L, Licea A, Possani LD. Modulation of cell membrane potential in cultured vascular endothelium. Am J Physiol (Cell Physiol) 1996; 270:C819–24.Google Scholar
  46. 46.
    Hofmann G, Bernabei PA, Crociani O et al. HERG K+ channels activation during β1 integrin-mediated adhesion to fibronectin induces an up-regulation of αvβ3 integrin in the preosteoclastic leukemia cell line FLG 29.1. J Biol Chem 2001; 276(7):4923–31.CrossRefPubMedGoogle Scholar
  47. 47.
    Cherubini A, Hofmann G, Pillozzi S et al. Human ether-a-go-go-related gene 1 channels are physically linked to β1 integrins and modulate adhesion-dependent signaling. Mol Biol Cell 2005; 16(6):2972–83.CrossRefPubMedGoogle Scholar
  48. 48.
    Becchetti A, Arcangeli A, Del Bene MR et al. Response to fibronectin-integrin interaction in leukaemia cells: delayed enhancing of a K+ current. Proc Biol Sci 1992; 248(1323):235–40.CrossRefPubMedGoogle Scholar
  49. 49.
    Wu X, Yang Y, Gui P et al. Potentiation of BK channels by α5β1 integrin activation in arteriolar smooth muscle. J Physiol 2008; 586:1699–1713.CrossRefPubMedGoogle Scholar
  50. 50.
    Yang Y, Wu X, Wu J et al. Integrin activation results in c-Src mediated phosphorylation and potentiation of Maxi K channels. FASEB J 2007; 21(5):A538.Google Scholar
  51. 51.
    Lal H, Guleria RS, Foster DM et al. Integrins: novel therapeutic targets for cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 2007; 5(2):109–32.CrossRefPubMedGoogle Scholar
  52. 52.
    Hayden MR, Sowers JR, Tyagi SC. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 2005; 4(1):9.CrossRefPubMedGoogle Scholar
  53. 53.
    del Zoppo GJ, Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 2006; 26(9):1966–75.CrossRefPubMedGoogle Scholar
  54. 54.
    Heerkens EH, Izzard AS, Heagerty AM. Integrins, vascular remodeling and hypertension. Hypertension 2007; 49(1):1–4.CrossRefPubMedGoogle Scholar
  55. 55.
    Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27(11):2302–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36(3):312–8.PubMedGoogle Scholar
  57. 57.
    Hultgårdh-Nilsson A, Durbeej M. Role of the extracellular matrix and its receptors in smooth muscle cell function: implications in vascular development and disease. Curr Opin Lipidol 2007; 18(5):540–5.CrossRefPubMedGoogle Scholar
  58. 58.
    Davis GE, Bayless KJ, Davis MJ et al. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 2000; 156:1489–1498.PubMedGoogle Scholar
  59. 59.
    Davis MJ, Wu X, Nurkiewicz T et al. Regulation of ion channels by integrins. Cell Biochemistry and Biophysics 2002; 36(1):41–66.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Peichun Gui
    • 1
  • Jun-Tzu Chao
    • 1
  • Xin Wu
    • 2
  • Yan Yang
    • 1
  • George E. Davis
    • 1
  • Michael J. Davis
    • 1
  1. 1.Dept. Medical Pharmacology and PhysiologyUniversity of Missouri School of MedicineColumbiaUSA
  2. 2.Department of Systems Biology and Translational MedicineCollege of Medicine Texas A&M Health Science CenterCollege StationUSA

Personalised recommendations